GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATHA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Athira Pharma, Inc. stock after losing 2.37%
(Updated on Apr 18, 2024)

Sell candidate since Mar 26, 2024 Loss -20.46% PDF

The Athira Pharma, Inc. stock price fell by -2.37% on the last day (Thursday, 18th Apr 2024) from $2.11 to $2.06. During the last trading day the stock fluctuated 8.86% from a day low at $2.02 to a day high of $2.20. The price has fallen in 6 of the last 10 days and is down by -17.6% for this period. Volume has increased on the last day by 87 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 198 thousand shares were bought and sold for approximately $407.46 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.00 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -24.87% during the next 3 months and, with a 90% probability hold a price between $1.50 and $2.70 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ATHA Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Athira Pharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.27 and $2.76. A break-up above any of these levels will issue buy signals. Athira Pharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Athira Pharma, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.179 between high and low, or 8.86%. For the last week, the stock has had daily average volatility of 10.74%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATHA) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Athira Pharma, Inc. to open at $2.09, and during the day (based on 14 day Average True Range), to move between $1.84 and $2.28, which gives a possible trading interval of +/-$0.215 (+/-10.44%) up or down from last closing price. If Athira Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 20.88% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.24, some $0.180 (8.74%) from the current price of $2.06, our system finds the risk reward not very attractive.

Is Athira Pharma, Inc. stock A Buy?

Athira Pharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.977 Sell Candidate Unchanged

Predicted Opening Price for Athira Pharma, Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$2.09 ( 1.63%) $2.06

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATHA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.27 10.32 %
R2 2.20 7.00 %
R1 2.16 4.95 %
Current price: 2.06
Support S1 2.03 -1.69 %
S2 1.98 -3.74 %
S3 1.91 -7.06 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.52 22.33 %
R2 2.46 19.17 %
R1 2.24 8.74 %
Current price 2.06
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Athira Pharma, Inc. Stock and on which exchange is it traded?
The symbol for Athira Pharma, Inc. is ATHA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Athira Pharma, Inc. Stock?
Athira Pharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Athira Pharma, Inc. Stock?
Athira Pharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Athira Pharma, Inc. Stock.

What's the current price of Athira Pharma, Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Athira Pharma, Inc. (ATHA) share was $2.06.

What is the 52-week high and low for Athira Pharma, Inc. Stock?
The 52-week high for Athira Pharma, Inc. Stock is $4.30 and the 52-week low is $1.33.

What is the market capitalization of Athira Pharma, Inc. Stock?
As of the 2024-04-18, the market capitalization of Athira Pharma, Inc. is 80.869M.

When is the next earnings date for Athira Pharma, Inc.?
The upcoming earnings date for Athira Pharma, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Athira Pharma, Inc.

Athira Pharma. Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkins... ATHA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT